Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-03-01 @ 9:45 AM
Study NCT ID:
NCT04089267
Status:
COMPLETED
Last Update Posted:
2019-09-13
First Post:
2019-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)
Sponsor:
Shenyang Sunshine Pharmaceutical Co., LTD.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-10
First Submit QC Date:
None
Study First Post Date:
2019-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-12
Last Update Post Date:
2019-09-13
Last Update Post Date Type:
ACTUAL